PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation

Peace Mabeta

doi:10.1515/acph-2016-0031

.blurhash-client-img { display: none !important; }

PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation

Acta Pharmaceutica

Volume 66 (2016): Issue 3 (September 2016)

By: Peace Mabeta

Open Access

|Jun 2016

1. J. K. Slack-Davis, K. H. Martin, R. W. Tilghman, M. Iwanicki, E. J. Ung, C. Autry, M. J. Luzzio, B. Cooper, J. C. Kath, W. G. Roberts and J. T. Parsons, Cellular characterization of a novel focal adhesion kinase inhibitor, J. Biol. Chem. 282 (2007) 14845-14852; DOI: 10.1074/jbc.M606695200.
Open DOI Search in Google Scholar
2. M. J. van Nimwegen and B. van der Water, Focal adhesion kinase: A potential target in cancer therapy, Biochem. Pharmacol. 73 (2007) 597-609; DOI: 10.1016/j.bcp.2006.08.011.
Open DOI Search in Google Scholar
3. J. D. Hood and D. A. Cheresh, Role of integrins in cell invasion and migration, Nat. Rev. Cancer 2 (2002) 91-100; DOI: 10.1038/nrc727.
Open DOI Search in Google Scholar
4. T. Miyazaki, H. Kato, M. Nakajima, M. Sohda, Y. Fukai, N. Masuda, R. Manda, M. Fukuchi, K. Tsukada and H. Kuwano, FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma, Br. J. Cancer 89 (2003) 140-145; DOI: 10.1038/sj.bjc.6601050.
Open DOI Search in Google Scholar
5. J. T. Parsons, J. Slack-Davis, R. Tilghman and W. G. Roberts, Focal adhesion kinase: Targeting adhesion signaling pathways for therapeutic intervention, Clin. Cancer Res. 14 (2008) 627-632; DOI: 10.1158/1078-0432.CCR-07-2220.
Open DOI Search in Google Scholar
6. J. M. Stiles, R. K. Rowntree, C. Amaya, D. Diaz, V. Kokta, D. C. Mitchell and A. B. Brad, Gene expression analysis reveals marked differences in the transcriptome of infantile hemangioma endothelial cells compared to normal dermal microvascular endothelial cells, Vasc. Cell 5 (2013) 1-12; DOI: 10.1186/2045-824X-5-6.
Open DOI Search in Google Scholar
7. L. V. Owens, L. Xu, G. A. Dent, X. Yang, G. C. Sturge, R. J. Craven and W. G. Cance, Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer, Ann. Surg. Oncol. 3 (1996) 100-105; DOI: 10.1007/BF02409059.
Open DOI Search in Google Scholar
8. D. D. Schlaepfer, C. R. Hauck and D. J. Sieg, Signaling through focal adhesion kinase, Prog. Biophys. Mol. Biol. 71 (1999) 435-478; DOI: 10.1016/S0079-6107(98)00052-2.
Open DOI Search in Google Scholar
9. L. A. Cohen and J. L. Guan, Mechanisms of focal adhesion kinase regulation, Curr. Cancer Drug Tar. 5 (2005) 629-643; DOI: 10.2174/156800905774932798.
Open DOI Search in Google Scholar
10. P. Mabeta and M. S. Pepper, Inhibition of hemangioma development in a syngeneic mouse model correlates with Bcl-2 suppression and the inhibition of Akt kinase activity, Angiogenesis 15 (2012) 131-139; DOI: 10.10007/s10456-011-9248-7.
Search in Google Scholar
11. H. P. Gerber, A. McMurtrey, J. Kowalski, M. Yan, B. A. Keyt, V. Dixit and N. Ferrara, Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation, J. Biol. Chem. 273 (1998) 30336-30343; DOI: 10.1074/jbc.273.46.30336.
Open DOI Search in Google Scholar
12. K. T. Sabapathy, M. S. Pepper, F. Kiefer, U. Möhle-Steinlein, F. Tacchini-Cottier, I. Fetka, G. Breier, W. Risau, P. Carmeliet, R. Montesano and E. F.Wagner, Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system, J. Cell Biol. 137 (1997) 953-963; DOI: 10.1083/jcb.137.4.953.
Open DOI Search in Google Scholar
13. P. Mabeta and M. S. Pepper, Altered expression of platelet factor 4 and basic fibroblast growth factor correlates with the inhibition of tumor growth in mice, Biomed. Pharmacol. 69 (2015) 186-190; DOI: 10.1016/j.biopha.2014.11.018.
Open DOI Search in Google Scholar
14. M. A. Cabrita, L. M. Jones, J. L. Quizi, L. A. Sabourin, B. C. McKay and C. L. Addison, Focal adhesion kinase inhibitors are potent anti-angiogenic agents, Mol. Oncol. 5 (2011) 517-526; DOI: 10.1016/ jmolonc.2011.10.004.
Open DOI Search in Google Scholar
15. S. Hiscox, P. Barnfather, E. Hayes, P. Bramble, J. Christensen, R. I. Nicholson and P. Barrett-Lee, Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells, Breast Cancer Res. Treat. 125 (2011) 659-669; DOI: 10.1007/s10549-010-0857-4.
Open DOI Search in Google Scholar
16. P. W. Bryant, Q. Zheng and K. M. Pumiglia, Focal adhesion kinase is a phospho-regulated repressor of Rac and proliferation in human endothelial cells, Biol. Open 15 (2012) 723-730; DOI: 10.1242/ bio.20121008.
Open DOI Search in Google Scholar
17. L. Portt, G. Norman, C. Clapp, M. Greenwood and M. T. Greenwood, Anti-apoptosis and cell survival: A review, Biochim. Biophys. Acta 1813 (2011) 238-259; DOI: 10.1016/j.bbamcr.2010.10.010.
Open DOI Search in Google Scholar
18. X. Zhao and J. L. Guan, Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis, Adv. Drug Deliver. Rev. 63 (2011) 610-615; DOI: 10.1016/j.addr.2010.11.001.
Open DOI Search in Google Scholar
19. S. K. Mitra, D. A. Hanson and D. D. Schlaepfer. Focal adhesion kinase: in command and control of cell motility, Nat. Rev. Mol. Cell Biol. 6 (2005) 56-68; DOI: 10.1038/nrm1549.
Open DOI Search in Google Scholar
20. B. Tavora, S. Batista, L. Reynolds, S. Jadeja, S. Robinson, V. Kostourou, I. Hart, M. Fruttiger, M. Parsons and K. M. Hodivala-Dilke, Endothelial FAK is required for tumour angiogenesis, EMBO Mol. Med. 2 (2010) 516-528; DOI: 10.1002/emmm.201000106.
Open DOI Search in Google Scholar
21. L. H. Xu, X. Yang, C. A. Bradham, D. A. Brenner, J. A. S. Baldwin, R. J. Craven and W. G. Cance, The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells, J. Biol. Chem. 275 (2000) 30597-30604; DOI: 10.1074/jbc. M910027199.
Open DOI Search in Google Scholar
22. C. Wiza, E. B. M. Nascimento and D. M. Ouwens, Role of PRAS40 in Akt and mTOR signaling in health and disease, Am. J. Physiol. Endocrinol. Metab. 302 (2012) E1453-E1460; DOI: 10.1152/ajpendo.00660.2011.
Open DOI Search in Google Scholar
23. H. Wang, Q. Zhang, Q. Wen, Y. Zheng, L. Philip, H. Jiang, J. Lin and W. Zheng, Proline-rich Akt substrate of 40 kDa (PRAS40): A novel downstream target of P13k/Akt signaling pathway, Cell Signal. 24 (2012) 17-24; DOI: 10.1016/j.cellsig.2011.08.010.
Open DOI Search in Google Scholar
24. I. Ruvinsky, N. Sharon, T. Lerer, H. Cohen, M. Stolovich-Rain, T. Nir, Y. Dor, P. Zisman and O. Meyuhas, Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis, Genes Dev. 19 (2005) 2199-2211; DOI: 10.1101/gad.351605.
Open DOI Search in Google Scholar
25. B. Gan, Y. Yoo and J. Guan, Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of S6 kinase activation and cell growth, J. Biol. Chem. 281 (2006) 37321-37329; DOI: 10.1074/jbc.M605241200.
Open DOI Search in Google Scholar
26. A. Porras and C. Guerrero, Role of p38α in apoptosis: Implication in cancer development and therapy, Atlas Genet. Cytogenet. Oncol. Haematol. 15 (2011) 316-326; DOI: 10.4267/2042/44993.
Open DOI Search in Google Scholar